BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 25154789)

  • 1. Tumor necrosis factor-α promotes the lymphangiogenesis of gallbladder carcinoma through nuclear factor-κB-mediated upregulation of vascular endothelial growth factor-C.
    Du Q; Jiang L; Wang X; Wang M; She F; Chen Y
    Cancer Sci; 2014 Oct; 105(10):1261-71. PubMed ID: 25154789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TNF-alpha promotes lymphangiogenesis and lymphatic metastasis of gallbladder cancer through the ERK1/2/AP-1/VEGF-D pathway.
    Hong H; Jiang L; Lin Y; He C; Zhu G; Du Q; Wang X; She F; Chen Y
    BMC Cancer; 2016 Mar; 16():240. PubMed ID: 26992854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RIP1 regulates TNF-α-mediated lymphangiogenesis and lymphatic metastasis in gallbladder cancer by modulating the NF-κB-VEGF-C pathway.
    Li CZ; Jiang XJ; Lin B; Hong HJ; Zhu SY; Jiang L; Wang XQ; Tang NH; She FF; Chen YL
    Onco Targets Ther; 2018; 11():2875-2890. PubMed ID: 29844685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular endothelial growth factor-D promotes growth, lymphangiogenesis and lymphatic metastasis in gallbladder cancer.
    Lin W; Jiang L; Chen Y; She F; Han S; Zhu J; Zhou L; Tang N; Wang X; Li X
    Cancer Lett; 2012 Jan; 314(2):127-36. PubMed ID: 22071224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCR7 mediates the TNF-α-induced lymphatic metastasis of gallbladder cancer through the "ERK1/2 - AP-1" and "JNK - AP-1" pathways.
    Hong H; He C; Zhu S; Zhang Y; Wang X; She F; Chen Y
    J Exp Clin Cancer Res; 2016 Mar; 35():51. PubMed ID: 27009073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. cIAP2 promotes gallbladder cancer invasion and lymphangiogenesis by activating the NF-κB pathway.
    Jiang X; Li C; Lin B; Hong H; Jiang L; Zhu S; Wang X; Tang N; Li X; She F; Chen Y
    Cancer Sci; 2017 Jun; 108(6):1144-1156. PubMed ID: 28295868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipopolysaccharide increases the release of VEGF-C that enhances cell motility and promotes lymphangiogenesis and lymphatic metastasis through the TLR4- NF-κB/JNK pathways in colorectal cancer.
    Zhu G; Huang Q; Huang Y; Zheng W; Hua J; Yang S; Zhuang J; Wang J; Ye J
    Oncotarget; 2016 Nov; 7(45):73711-73724. PubMed ID: 27713159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial growth factor-C promotes the growth and invasion of gallbladder cancer via an autocrine mechanism.
    Chen Y; Jiang L; She F; Tang N; Wang X; Li X; Han S; Zhu J
    Mol Cell Biochem; 2010 Dec; 345(1-2):77-89. PubMed ID: 20734221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-mobility group box 1 protein activating nuclear factor-κB to upregulate vascular endothelial growth factor C is involved in lymphangiogenesis and lymphatic node metastasis in colon cancer.
    Li Y; He J; Zhong D; Li J; Liang H
    J Int Med Res; 2015 Aug; 43(4):494-505. PubMed ID: 26001393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased lymphangiogenesis in joints of mice with inflammatory arthritis.
    Zhang Q; Lu Y; Proulx ST; Guo R; Yao Z; Schwarz EM; Boyce BF; Xing L
    Arthritis Res Ther; 2007; 9(6):R118. PubMed ID: 17997858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shikonin Suppresses Lymphangiogenesis via NF-κB/HIF-1α Axis Inhibition.
    Prangsaengtong O; Jantaree P; Lirdprapamongkol K; Svasti J; Koizumi K
    Biol Pharm Bull; 2018; 41(11):1659-1666. PubMed ID: 30381665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peritumoral lymphangiogenesis induced by vascular endothelial growth factor C and D promotes lymph node metastasis in breast cancer patients.
    Zhao YC; Ni XJ; Li Y; Dai M; Yuan ZX; Zhu YY; Luo CY
    World J Surg Oncol; 2012 Aug; 10():165. PubMed ID: 22906075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of lymphangiogenesis in human lymphatic endothelial cells by simultaneously blocking VEGF-C and VEGF-D/VEGFR-3 with norcantharidin.
    Liu ZY; Qiu HO; Yuan XJ; Ni YY; Sun JJ; Jing W; Fan YZ
    Int J Oncol; 2012 Nov; 41(5):1762-72. PubMed ID: 22922710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IGFBP7 functions as a potential lymphangiogenesis inducer in non-small cell lung carcinoma.
    Zhao W; Wang J; Zhu B; Duan Y; Chen F; Nian W; Sun J; Zhang B; Tong Z; Chen Z
    Oncol Rep; 2016 Mar; 35(3):1483-92. PubMed ID: 26706909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different patterns of NF-κB and Notch1 signaling contribute to tumor-induced lymphangiogenesis of esophageal squamous cell carcinoma.
    Su C; Chen Z; Luo H; Su Y; Liu W; Cai L; Wang T; Lei Y; Zhong B
    J Exp Clin Cancer Res; 2011 Sep; 30(1):85. PubMed ID: 21939555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. OxLDL promotes lymphangiogenesis and lymphatic metastasis in gastric cancer by upregulating VEGF‑C expression and secretion.
    Ma C; Xie J; Luo C; Yin H; Li R; Wang X; Xiong W; Zhang T; Jiang P; Qi W; Zhou T; Yang Z; Wang W; Ma J; Gao G; Yang X
    Int J Oncol; 2019 Feb; 54(2):572-584. PubMed ID: 30483757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphatic spread of ductal pancreatic adenocarcinoma is independent of lymphangiogenesis.
    Sipos B; Kojima M; Tiemann K; Klapper W; Kruse ML; Kalthoff H; Schniewind B; Tepel J; Weich H; Kerjaschki D; Klöppel G
    J Pathol; 2005 Nov; 207(3):301-12. PubMed ID: 16161179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrin α6 overexpression promotes lymphangiogenesis and lymphatic metastasis via activating the NF-κB signaling pathway in lung adenocarcinoma.
    Ren S; Wang J; Xu A; Bao J; Cho WC; Zhu J; Shen J
    Cell Oncol (Dordr); 2022 Feb; 45(1):57-67. PubMed ID: 35025009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammation induces lymphangiogenesis through up-regulation of VEGFR-3 mediated by NF-kappaB and Prox1.
    Flister MJ; Wilber A; Hall KL; Iwata C; Miyazono K; Nisato RE; Pepper MS; Zawieja DC; Ran S
    Blood; 2010 Jan; 115(2):418-29. PubMed ID: 19901262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WISP-1 promotes VEGF-C-dependent lymphangiogenesis by inhibiting miR-300 in human oral squamous cell carcinoma cells.
    Lin CC; Chen PC; Lein MY; Tsao CW; Huang CC; Wang SW; Tang CH; Tung KC
    Oncotarget; 2016 Mar; 7(9):9993-10005. PubMed ID: 26824419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.